
CUC Inc. is a global healthcare organization headquartered in Japan and listed on the Tokyo Stock Exchange (9158.T). We operate across Japan, Indonesia, Vietnam, and the United States, with a mission centered on creating hope through healthcare—for patients, healthcare teams, and the society. Through CUC America, we partner with physicians to build sustainable, patient-centered practices. Our focus is on enabling clinical teams to operate effectively by supporting day-to-day operations, optimizing workflows, strengthening staffing models, and improving access and patient flow—so clinicians can stay focused on delivering high-quality care. As healthcare continues to shift toward outpatient and office-based settings, we help practices develop the scalable processes, infrastructure, and governance needed for responsible growth while preserving clinical autonomy. In 2026, we plan to expand minimally invasive musculoskeletal embolotherapy in the United States through physician partnerships and structured training support. Our goal is to improve patient access to minimally invasive treatment options for inflammatory and chronic pain conditions.
CUC America, Inc.
32743 23 Mile Road
Suite 110
Chesterfield, MI 48047